Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India

Vaccine

Volumn 24, Issue 14, 2006, Pages 2585-2593

  Kumar, Sanjeev ^a   Aggarwal, Priya ^a   Vajpayee, Madhu ^a   Pandey, R M ^a   Seth, Pradeep ^a,b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Seth Research Foundation   (India)

Author keywords

DNA vaccination; DNA MVA prime boost; HIV 1 subtype C

Indexed keywords

DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PROTEINASE; RECOMBINANT DNA; RECOMBINANT GAGPROTEASE; RECOMBINANT GLYCOPROTEIN GP 120; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN BHK; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENE CONSTRUCT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOSTIMULATION; INDIA; INOCULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TREATMENT RESPONSE; VACCINE PRODUCTION; VACCINIA VIRUS; VIRUS RECOMBINANT;

AIDS VACCINES; ANIMALS; CELL LINE; GENE PRODUCTS, ENV; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INDIA; MICE; MICE, INBRED BALB C; VACCINES, DNA; VACCINIA VIRUS;

EID: 33344458280     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.12.032     Document Type: Article

References (37)

1. UNAIDS. Report on the Global HIV/AIDS Epidemic. The Barcelona Report July 2003, http://www.unaids.org/barcelona/presskit/barcelona.report/contents.html.
2. S. Rowland-Jones, J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, and S. McAdam HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women Nat Med 1 1995 59 64
3. S.L. Rowland-Jones, T. Dong, K.R. Fowke, J. Kimani, P. Krausa, and H. Newell Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi J Clin Invest 102 1998 1758 1765
4. J.W. Shiver, T.M. Fu, L. Chen, D.R. Casimiro, M.E. Davies, and R.K. Evans Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Nature 415 6869 2002 331 335
5. S.C. Gilbert, T.J. Blanchard, T. Hanke, K.J. Robson, and C.M. Hannan Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara Nat Med 4 1998 397 402
6. R. Amara, F. Villinger, and J.D. Altman Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 292 2001 69 74
7. NACO, National AIDS Control Organization. HIV/AIDS Indian Scenario, 2003, http://www.naco.nic.in/vsnaco/indianscene/welcome.html.
8. A.K. Sahni, V.V. Prasad, and P. Seth Genomic diversity of human immunodeficiency virus type-1 in India Int J STD AIDS 13 2 2002 115 118
9. I.D. Tatt, K.L. Barlow, A. Nicool, and J.P. Clewley The public health significance of HIV-1 subtypes AIDS 15 2001 S59 S71
10. C.M. Rodenburg, Y. Li, S.A. Trask, Y. Chen, J. Decker, and D.L. Robertson UNAIDS and NIAID Networks for HIV Isolation and Characterization. Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents AIDS Res Hum Retroviruses 17 2 2001 161 168
11. M. Peeters, R. Vincent, J.L. Perret, M. Lasky, D. Patrel, and F. Liegeois Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses J Acquir Immune Defic Syndr Hum Retrovirol 20 2 1999 115 121
12. D. Cecilia, S.S. Kulkarni, S.P. Tripathy, R.R. Gangakhedkar, R.S. Paranjape, and D.A. Gadkari Absence of coreceptor switch with disease progression in human immunodeficiency Virology 271 2 2000 253 258
13. S. Kumar, and P. Seth Efficient expression of Gag protein by recombinant Modified Vaccinia Ankara Virus (MVA) with HIV-1 Indian Subtype C gagprotease gene segments Gene Ther Mol Biol 8 2004 193 200
14. S. Kumar, and P. Seth Immunogenicity of recombinant modified Vaccinia Ankara Viruses (rMVA) Expressing HIV-1 Indian subtype C gag-protease and env-gp120 genes in mice Viral Immunol 17 2004 574 579
15. A. Arora, J.L. Fahey, and P. Seth DNA vaccine for the induction of immune responses against HIV-1 subtype C envelope gene in mice Gene Ther Mol Biol 6 2001 79 89
16. P. Chugh, and P. Seth Development of HIV-1 subtype C Gag based DNA vaccine construct Gene Ther Mol Biol 8 2004 327 334
17. P. Chugh, and P. Seth Induction of broad based immune response against HIV-1 subtype C gag DNA vaccine in mice Viral Immunol 17 2004 423 435
18. A. Lalvani, R. Brookes, S. Hambleton, W.J. Britton, A.V. Hill, and A.J. McMichael Rapid effector function in CD8q memory T cells J Exp Med 186 1997 859 865
19. R.R. Amara, F. Villinger, S.I. Staprans, J.D. Altman, D.C. Montefiori, and N.L. Kozyr Different patterns of immune responses but similar control of a simian human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines J Virol 76 2002 7625 7631
20. T. Hanke, R.V. Samuel, T.J. Blanchard, V.C. Neumann, T.M. Allen, and J.E. Boyson Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen J Virol 73 1999 7524 7532
21. V.S. Moorthy, S. McConkeya, M. Robertsa, P. Gotharda, N. Arulananthama, and P. Deganoa Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers Vaccine 21 17-18 2003 1995 2002
22. H. McShane Prime-boost immunization strategies for infectious diseases Curr Opin Mol Ther 4 1 2002 23 27
23. E. Raz, D.A. Carson, S.E. Parker, T.B. Parr, A.M. Abai, and G. Aichinger Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses Proc Natl Acad Sci USA 91 20 1994 9519 9523
24. D.J. Shedlock, and D.B. Weiner DNA vaccination: antigen presentation and the induction of immunity J Leukoc Biol 68 6 2000 793 806
25. S. Casares, T.D. Brumeanu, A. Bot, and C.A. Bona Protective immunity elicited by vaccination with DNA encoding for a B cell and a T cell epitope of the A/PR/8/34 influenza virus Viral Immunol 10 3 1997 129 136
26. J.W. Shiver, M.E. Davies, Y. Yasutomi, H.C. Perry, D.C. Freed, and N.L. Letvin Anti-HIV env immunities elicited by nucleic acid vaccines Vaccine 15 8 1997 884 887
27. J.W. Shiver, H.C. Perry, M.E. Davies, D.C. Freed, and M.A. Liu Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotidevaccination Ann N Y Acad Sci 772 1995 198 208
28. D.M. Feltquate, S. Heaney, R.G. Webster, and H.L. Robinson Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization J Immunol 158 5 1997 2278 2284
29. J. Hinkula, C. Svanholm, S. Schwartz, P. Lundholm, M. Brytting, and G. Engstrom Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type1 regulatory genes J Virol 71 7 1997 5528 5539
30. Y. Asakura, P. Lundholm, A. Kjerrstrom, R. Benthin, E. Lucht, and J. Fukushima DNA-plasmids of HIV-1 induce systemic and mucosal immune responses Biol Chem 380 3 1999 375 379
31. T. Hanke, T.J. Blanchard, J. Schneider, C.M. Hannan, M. Becker, and S.C. Gilbert Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime Vaccine 16 5 1998 439 445
32. R.R. Amara, F. Villinger, J.D. Altman, S.L. Lydy, S.P. O'Neil, and S.I. Staprans Control of a mucosal challenge and prevention of clinical AIDS in rhesus monkeys by a multiprotein DNA/MVA vaccine Science 292 2001 69 74
33. T.M. Allen, T.U. Vogel, D.H. Fuller, B.R. Mothe, S. Steffen, and J.E. Boyson Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen J Immunol 164 9 2000 4968 4978
34. T.A. Galvin, J. Muller, and A.S. Khan Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina Vaccine 18 23 2000 2566 2583
35. D. Rodriguez, J.R. Rodriguez, M. Llorente, I. Vazquez, P. Lucas, and M. Esteban A human immunodeficiency virus type 1 Env-granulocyte-macrophage colony-stimulating factor fusion protein enhances the cellular immune response to Env in a vaccinia virus-based vaccine J Gen Virol 80 Pt 1 1999 217 223
36. B.S. Graham, and P.F. Wright Candidate AIDS vaccines N Engl J Med 333 1995 1331 1339
37. R.R. Amara, F. Villinger, S.I. Staprans, J.D. Altman, D.C. Montefiori, and N.L. Kozyr Different patterns of immune responses but similar control of a simian human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines J Virol 76 2002 7625 7631